» Articles » PMID: 32682567

Modular, Circuit-Based Interventions Rescue Hippocampal-Dependent Social and Spatial Memory in a 22q11.2 Deletion Syndrome Mouse Model

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2020 Jul 20
PMID 32682567
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: 22q11.2 deletion syndrome (22qDS) manifests with myriad symptoms, including multiple neuropsychiatric disorders. Complications associated with the polygenic haploinsufficiency make 22qDS symptoms particularly difficult to manage with traditional therapeutic approaches. However, the varying mechanistic consequences often culminate to generate inappropriate regulation of neuronal circuit activity. We explored whether managing this aberrant activity in adults could be a therapeutically beneficial strategy.

Methods: To assess and dissect hippocampal circuit function, we performed functional imaging in acute slices and targeted eloquent circuits (specific subcircuits tied to specific behavioral tasks) to provide relevant behavioral outputs. For example, the ventral and dorsal CA1 regions critically support social and spatial discrimination, respectively. We focally introduced chemogenetic constructs in 34 control and 24 22qDS model mice via adeno-associated viral vectors, driven by excitatory neuron-specific promoter elements, to manipulate circuit recruitment in an on-demand fashion.

Results: 22qDS model mice exhibited CA1 excitatory ensemble hyperexcitability and concomitant behavioral deficits in both social and spatial memory. Remarkably, acute chemogenetic inhibition of pyramidal cells successfully corrected memory deficits and did so in a regionally specific manner: ventrally targeted constructs rescued only social behavior, while those expressed dorsally selectively affected spatial memory. Additionally, manipulating activity in control mice could recapitulate the memory deficits in a regionally specific manner.

Conclusions: These data suggest that retuning activity dysregulation can rescue function in disease-altered circuits, even in the face of a polygenetic haploinsufficiency with a strong developmental component. Targeting circuit excitability in a focal, modular manner may prove to be an effective therapeutic for treatment-resistant symptoms of mental illness.

Citing Articles

Effects of repeated developmental GLP-1R agonist exposure on young adult behavior and hippocampal structure in mice.

Cerroni C, Steiner A, Seanez L, Kwon S, Lewis A Neurosci Lett. 2023; 808:137299.

PMID: 37196974 PMC: 10330515. DOI: 10.1016/j.neulet.2023.137299.


Effects of repeated developmental GLP-1R agonist exposure on adult behavior and hippocampal structure in mice.

Cerroni C, Steiner A, Seanez L, Kwon S, Lewis A bioRxiv. 2023; .

PMID: 37131808 PMC: 10153236. DOI: 10.1101/2023.04.21.537724.


Neuronal circuitry for recognition memory of object and place in rodent models.

Chao O, Nikolaus S, Yang Y, Huston J Neurosci Biobehav Rev. 2022; 141:104855.

PMID: 36089106 PMC: 10542956. DOI: 10.1016/j.neubiorev.2022.104855.


The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia.

Nehme R, Pietilainen O, Artomov M, Tegtmeyer M, Valakh V, Lehtonen L Nat Commun. 2022; 13(1):3690.

PMID: 35760976 PMC: 9237031. DOI: 10.1038/s41467-022-31436-8.


A novel role for the lateral habenula in fear learning.

Sachella T, Ihidoype M, Proulx C, Pafundo D, Medina J, Mendez P Neuropsychopharmacology. 2022; 47(6):1210-1219.

PMID: 35217797 PMC: 9018839. DOI: 10.1038/s41386-022-01294-5.


References
1.
Gur R, Yi J, McDonald-McGinn D, Tang S, Calkins M, Whinna D . Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities. Mol Psychiatry. 2014; 19(11):1205-11. PMC: 4450860. DOI: 10.1038/mp.2013.189. View

2.
Schneider M, Schaer M, Mutlu A, Menghetti S, Glaser B, Debbane M . Clinical and cognitive risk factors for psychotic symptoms in 22q11.2 deletion syndrome: a transversal and longitudinal approach. Eur Child Adolesc Psychiatry. 2013; 23(6):425-36. PMC: 4042012. DOI: 10.1007/s00787-013-0469-8. View

3.
Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C . Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil. 2008; 30(4):763-73. DOI: 10.1016/j.ridd.2008.10.007. View

4.
Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M . Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry. 2009; 48(11):1060-1068. DOI: 10.1097/CHI.0b013e3181b76683. View

5.
Thompson K, Khajehali E, Bradley S, Navarrete J, Huang X, Slocum S . DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs and . ACS Pharmacol Transl Sci. 2019; 1(1):61-72. PMC: 6407913. DOI: 10.1021/acsptsci.8b00012. View